Nurix Therapeutics Inc.

14.16
-1.29 (-8.35%)
At close: Mar 03, 2025, 3:59 PM
14.47
2.15%
After-hours: Mar 03, 2025, 04:03 PM EST

Nurix Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
PE Ratio -7.67 -2.35 -3.63 -10.55 -15.45 -34.03 -32.48
PEG Ratio -0.88 0.10 -0.14 9.70 -0.04 6.69 n/a
PS Ratio 27.21 4.39 15.59 41.55 37.49 23.73 8.18
PB Ratio 2.82 1.69 1.98 3.61 2.30 -12.79 -8.31
P/FCF Ratio -8.16 -3.77 -3.5 -13.73 -144.18 -703.28 -9.2
P/OCF Ratio -8.6 -4.15 -3.77 -14.65 -8.35K 1.23K -9.67
OCF/S Ratio -3.16 -1.06 -4.14 -2.84 -0.00 0.02 -0.85
Debt / Equity Ratio 0.05 0.15 0.04 0.04 n/a n/a n/a
Quick Ratio 6.46 3.40 4.52 4.70 6.70 2.44 1.24
Current Ratio 6.46 3.40 4.51 4.70 6.70 2.44 1.24
Asset Turnover 0.08 0.22 0.09 0.06 0.04 0.71 0.82
Interest Coverage n/a n/a n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.37 -0.72 -0.55 -0.34 -0.15 0.38 0.26
Return on Assets (ROA) -0.29 -0.4 -0.4 -0.25 -0.11 -0.49 -0.21
Return on Capital (ROIC) -0.37 -0.58 -0.53 -0.29 -0.18 -0.8 -0.78
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% -145.69% 72.02% 79.56% -273.14% -44.71% -8.18%
Net Profit Margin -354.85% -186.98% -429.87% -393.93% -242.66% -69.74% -25.18%
Pretax Profit Margin -354.36% -186.98% -466.93% -393.49% -357.9% -68.97% -23.82%
Operating Profit Margin -390.52% -201.41% -476.01% -396.26% -364.66% -71.46% -26.01%
FCF Margin -333.38% -116.6% -445.42% -302.61% -26% -3.37% -88.84%
EBITDA Margin -390.52% -183.68% -448.03% -375.81% -352.43% -63.9% -18.03%